3 Firms Steer Upsized Biotech IPOs Raising $385M Combined
Biotechnology firms Apogee Therapeutics Inc. and Sagimet Biosciences Inc. began trading Friday after pricing upsized initial public offerings that raised a combined $385 million, guided by three law firms, adding life...To view the full article, register now.
Already a subscriber? Click here to view full article